Find Your Something
A resident physician and T1D dad—who also lives with an autoimmune disease—shares his call to action to support Breakthrough T1D…
On Medicare? Accessing CGMs Just Got Easier
A recent update to continuous glucose monitor (CGM) coverage requirements will make it easier for people covered by Medicare to…
FDA Advisory Committee Recommends that Teplizumab Receives Approval
An FDA Advisory Committee weighed the evidence, and the results were positive: They recommended that the FDA approve teplizumab for…
Breakthrough T1D Advocates Have Been Hard at Work
Through these meetings, advocates give a voice to those impacted by T1D.
The CDC Updates its Guidelines to Prioritize T1D
On March 29, 2021, the U.S. Centers for Disease Control and Prevention (CDC) updated its guidelines to include type 1…
Special Diabetes Program (SDP) Renewed for Three Years!
One of Breakthrough T1D’s top legislative priorities has been achieved with the enactment of a three-year renewal of the Special…
Delay on Rule That Would Eliminate Medicare Part D Drug Rebates
On January 29, 2021, the Biden Administration delayed implementation of a recently adopted rule that would largely eliminate drug rebates…
Department of Health & Human Services Freezes Rule Related to Insulin
As you may have heard from reports in the media the Biden Administration froze a recent regulation on insulin. Want to know what the headlines mean? Read on to get…
Cass Freeland Builds Relationships with Political Power Players
NDAM Profile: Breakthrough T1D advocate Cass Freeland’s expertise in connecting with policy makers demonstrates The Power of Us.
Medicare Proposes Expanded Coverage of Continuous Glucose Monitors
The Centers for Medicare & Medicaid Services (CMS) proposed a new rule on October 27, 2020 that would expand coverage…
